Actinium Pharmaceuticals, Inc. (ATNM): Total Liabilities
$43.94M
As of 2025-12-31
$9.86M
As of 2026-06-30
-2.7%
3-year compound annual growth
+54.0%
5-year compound annual growth
+25.3%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $43.94M | -0.5% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $44.14M | -2.1% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $45.07M | -5.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $47.71M | +597.2% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $6.84M | +34.8% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $5.08M | -15.7% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $6.03M | -0.8% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $6.08M | +30.2% | 2020-05-08, Balance as of period end |
| 2017-12-31 | $4.67M | +3.2% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $4.52M | -2.0% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $4.61M | -51.4% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $9.49M | +29.6% | 2016-03-11, Balance as of period end |
| 2013-12-31 | $7.33M | +57.8% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $4.64M | n/m | 2014-02-28, Balance as of period end |
| 2011-12-31 | $84.5K | -10.9% | 2012-04-12, Balance as of period end |
| 2010-12-31 | $94.8K | n/a | 2012-04-12, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $7.06M | +21.1% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
Compare ATNM, IXHL, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗